Stay updated on AK002 for Eosinophilic Gastritis Clinical Trial
Sign up to get notified when there's something new on the AK002 for Eosinophilic Gastritis Clinical Trial page.

Latest updates to the AK002 for Eosinophilic Gastritis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.8%
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check34 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check63 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check70 days agoChange DetectedThe page has undergone significant content removal regarding a Phase 3 study of lirentelimab (AK002) for Eosinophilic Gastritis, including detailed inclusion and exclusion criteria, while a new revision number has been added.SummaryDifference27%
- Check85 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to AK002 for Eosinophilic Gastritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK002 for Eosinophilic Gastritis Clinical Trial page.